HELP Helus Pharma
$7.67
Helus Pharma (HELP) is expected to report earnings on February 12, 2027, before the market open. The consensus earnings estimate is a loss of $0.68 per share.
Helus Pharma Missed Consensus Estimates
Monday, November 16, 2026 · 6:00 AM ET
Earnings Date
3rd Quarter, Dec 2026
Feb 12
Friday · 7:30 AM ET
Earnings Whisper
-
vs ($0.68)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$7.67
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Helus Pharma
Helus Pharma is a clinical stage pharmaceutical company. Its lead candidate includes HLP003 and HLP004. Helus Pharma, formerly known as Cybin Inc., is based in BOSTON.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Charts powered in part by Lightweight Charts™ by TradingView.